To properly mitigate risks AI poses, understanding these limits and maximizing the benefits is vital. Unlike
previous technological advancements in the medical field, patients can now communicate freely and more
naturally with advanced AI systems, providing them with greater assistance. Striking a balance between these
opportunities and limitations allows researchers to create AI frameworks which enhance safety measures
without impeding ethical boundaries in pharmacy practice [1].
Ai In Clinical Pharmacy Practice
AI enhances clinical decision-making and operational efficacy by integrating clinical pharmacy services into
the system. Advancements in AI such as CDSS (Clinical Decision Support System) help the healthcare
professionals to make prescriptions by sourcing information from medical literature and treatment guidelines
[2]. To control the rising rates of resistance and treatment failures, AI aids in the process of individualized
medicine by dose optimization, medication adherence monitoring, and improved patient compliance. The other
advancements, such as machine learning and natural language processing, are revolutionizing the fields of
pharmacovigilance by early identification of adverse drug reactions from electronic health data [3]. In
inventory management, AI automation benefits the organizations through minimizing drug waste and stock
shortages [2]. Tele pharmacy, remote consultation, and workflow automation are proven effective models of
pharmaceutical care by utilization of AI [4].
Evolving Role Of Clinical Pharmacists In Modern Health Care
The role of clinical pharmacists in healthcare is wide and viable. They ensure the safety and efficacy of the
pharmaceuticals, conducting pharmacovigilance programs to report and prevent adverse drug reactions,
providing clinical pharmacy services such as medication reconciliation, treatment chart review to take
decisions customised to unique patient profiles.
Through patient-centred education, adherence promotion, and lifestyle advising, they play a critical role in the
long-term management of chronic conditions, including diabetes, hypertension, and asthma. They actively
participate in pharmacoeconomic analysis for the financial benefits of both the patient and the healthcare
organisation. The other notable clinical pharmacist responsibilities including drug information retrieval,
dosage optimisation and inventory management. The pharmacogenomics research and the drug utilisation
evaluation held by clinical pharmacists guarantees the identification of superior pharmacological care in this
day of daily changing healthcare guidelines [5].
Regulatory And Compliance Aspect Of Ai
1. Global Regulatory Frameworks Governing AI
At a global scale, the application of AI technologies in the field of healthcare is predominantly controlled
under pre-existing regulations of medical devices, especially under Software as a Medical Device (SaMD).
However, these frameworks do not tend to include AI systems that focus on managing lifestyle, performing
administrative functions, or systems that offer clinical guidance. This is designed on the premise that qualified
professionals will reasonably based clinical decisions utilize these tools for navigation systems. At the
moment, the majority of jurisdictions take an approach towards the regulation of AI technologies in health
care. This encompasses guidelines of a professional nature, voluntary standards, and industry codes of conduct.
While these frameworks maintain high expectations from both developers (the planners, funders, and
maintainers of AI-MDs) and users (the healthcare providers who deploy AI tools into the workflows), there is
no formal enforcement. The primary benefit of soft-law is its flexibility when addressing changes in
technology. However, the fact that organizations have the option of complying or not brings forth the most
significant challenge [13].
2. Compliance Challenges in Transparency, Fairness, and Data Protection
AI applications in pharmacy include automated drug dispensing, dose optimization, and predictive analytics
for medication adherence. But pharmacists face certain difficulties regarding lack of control over data, ethical